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INTRODUCTION 
In this paper we discuss the ethical and policy challenges presented by the construction and use 
of biobanks and electronic health records systems, with a particular focus on how these 
resources implicate certain types of security concerns for patients, families, health care 
providers and institutions. These two technology platforms are selected for special emphasis in 
this paper for two reasons. First and foremost, there is a close connection between them. 
Indeed, of the many accepted definitions, this one from the German National Bioethics 
Commission provides a sense of this close connection and the great power and reflects the 
great power these two separate platforms provide to probe more deeply the connection 
between genotype and phenotype:   
 
“…[B]iobanks are defined as collections of samples of human bodily substances (e.g., 
cells, tissues, blood or DNA as the physical medium of genetic information) that are or 
can be associated with personal data and information on their donors.”  
 
Second, these two topics implicate both clinical ethics issues (those arising at the bedside for 
health care providers and patients), and human research ethics issues (issues arising for 
scientists, research subjects, ethics review bodies and regulatory authorities).  Both of these 
sub-specialty areas confront similar and complementary ethical issues; for example, issues 
arising from the nature and adequacy of informed consent, the sufficiency of systems to protect 
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personal privacy and confidentiality,  or the need to balance concerns relating to data security 
and the need to know.  A growing research base supports calls for more attention to these 
issues, and yet current professional ethics frameworks and policy consultation methods are 
poorly organized and ill-equipped to anticipate and fully address ethical issues in health 
information technology generally, or to provide adequate ethical assessment of the tools that 
elicit these issues.   
Our strategy is to orient readers to the history and context of these issues, to frame 
several key challenges for researchers and policy makers, and then to close with several 
recommendations for next steps. 
 
BIOBANKS 
From the very early history of clinical pathology, studies of archived human biological materials 
(HBMs) including specimens of blood, DNA, but also bone, organs and other tissues have played 
a prominent role in the diagnosis and treatment of diseases as diverse as cancer, heart disease, 
diabetes, and stroke,1 as well as other diseases of significant public health impact.2
                                                          
1 Ackerknecht E. Medicine at the Paris Hospital, 1794–1848 (1967); Baltimore: Johns 
Hopkins University Press;  Korn D. Contribution of the Human Tissue Archive to the 
advancement of medical knowledge and public health. In: National Bioethics Advisory 
Commission. Research Involving Human Biological Materials: ethical issues and policy guidance, 
Vol. II: commissioned papers. Bethesda, MD: US Government Printing Office; 2000: E1–E30. 
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exists on every continent of the globe, including Antarctica. Figure 1 provides a graphic 
illustration of many of these repositories, principally those limited to national or other 
institutional repositories. While no global census of the number of samples and specimens has 
been undertaken, one of the first domestic U.S. accounting was conducted by the National 
Bioethics Advisory Commission (NBAC) which estimated that 282 million specimens were stored 
in the nation’s pathology laboratories, newborn screening collections, forensic DNA banks, 
blood banks, umbilical cord banks, organ procurement organizations, tissue banks, and  
research-related repositories 
that are maintained for 
longitudinal studies. 3
                                                                                                                                                                                           
2 Khoury MJ, Little J. Human Genome Epidemiology Reviews: The beginning of 
something HuGE. American Journal of Epidemiology 2000;151(1):2-3. 
  This 
data was later updated by 
Eiseman, who adjusted the 
figure upwards to more than 
 
3 National Bioethics Advisory Commission (2000). Research Involving Human Biological 
Materials: ethical issues and policy guidance, Vol II: Commissioned papers. Bethesda, MD: US 
Government Printing Office;   Eiseman E. The National Bioethics Advisory Commission: 
contributing to public policy (MR-1546-STPI). Santa Monica (CA): RAND Corporation; 2003. 
 
Figure 1- Biobanks Ar und the World 
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350 million.4 Both figures are likely to be substantial underestimates since they do not include 
proprietary databases, classified military banks, or privately maintained collections, let alone all 
the “fridges” maintained in university and hospital laboratories. A conservative estimate of the 
samples stored in repositories around the world must now exceed one billion.  So ubiquitous 
are these banks, and their potential, that Time magazine listed biobanks one of the “Ten Ideas 
That Are Changing the World Right Now”.5
Common to the establishment and maintenance of every bank -- domestic or 
international, public or proprietary -- are a set of ethical and policy issues that must be 
addressed from the moment the banks are designed through the collection and storage of 
materials, and which continue when materials are shared and disseminated with others. 
  
 
Ethical Issues in the Collection, Storage and Use of Human Biological Materials 
                                                          
4  Eiseman, E., and Haga, S.B. (1999) Handbook of Human Tissue Resources: A National 
Resource of Human Tissue Sample, Santa Monica, CA: RAND, MR-954-OSTP.; Eiseman, E., 
Bloom, G., Brower, J., Clancy, N., & Olmsted, S.S. (2003a). Case Studies of Existing Human Tissue 
Repositories: "Best Practices" for a Biospecimen Resource for the Genomic and Proteomic Era, 
Santa Monica, CA: RAND, MG-120-NDC/NCI. 
 
5 Time, March 16, 2009. The other nine: Jobs Are the New Assets; Recycling the Suburbs; 
The New Calvinism; Reinstating The Interstate; Amortality; Africa: Open for Business; The Rent-
a-Country; Survival Stores; and Ecological Intelligence. 
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 The ‘standard’ clinical paradigm describing the nature of the encounter between a 
patient and her physician may be summed up as follows: the virtuous physician, respectful of 
individual patients, will seek permission to undertake interventions (treatment, surgery, etc.) 
that are jointly believed to be in the particular patient’s best interest. In so doing, the respectful 
clinician provides sufficient information to allow an informed choice by the patient to be 
treated, while at the same time  protecting certain information from the gaze of those who 
have no need to know (or see) it.6
 Similarly, the “standard’ research” paradigm describing the nature of the relationship 
between an investigator and prospective research subject may be described as follows: the 
virtuous researcher is one who designs studies that answer valuable and valid questions, avoids 
conflicts of interest that compromise scientific objectivity and bias, submits protocols for prior 
scientific and ethics review and approval by an Institutional Review Board that includes clearly 
written consent forms and descriptions of how consent will be sought, recruits participants 
while protecting vulnerable populations from exploitation, and conducts the study according to 
accepted scientific standards of rigor, analysis and reporting.
 
7
                                                          
6 A voluminous literature exists on these topics. See for example, Pellegrino ED and 
Thomasma DC (1984) For the Patient’s Good. New York: Oxford; Ramsey, P. For the Patient’s 
Good (1960) Princeton University Press; Veatch RM. A Theory of Medical Ethics (1981), New York: 
Basic Books. 
 
7 An equally voluminous literature exists on this topic, but one paper in particular is 
highlighted because of its enduring impact. Beecher, HK. Ethics in Clinical Research. (1966): 
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 These two “paradigms” may only be ideals, but whatever the valence we give to them, 
they are both being subjected to challenges arising from genomic science.  The esteemed 
Canadian physician, William Osler wrote in 1892: “If it were not for the great variability among 
individuals, medicine might as well be a science and not an art.” This statement was prescient in 
many ways. Little did he know that a little more than a century later, researchers with the 
complete sequence of the human genome would turn their attention to the minute but 
important differences between people at the level of the individual letters of the genetic 
alphabet – A,C,T,G. These differences, called single nucleotide polymorphisms (SNPs) help to 
explain why some people respond to drugs and other do not, why some are at increased risk of 
succumbing to certain diseases while other are not.  Many of the issues arising from these 
developments were first outlined by NBAC in 2000,8
                                                                                                                                                                                           
New England Journal of Medicine 274(24):1354-1360. In a memorable quotation, Beecher 
described the most reliable safeguard for ensuring ethical experimentation is: “…the presence 
of an intelligent, informed, conscientious, compassionate, responsible investigator.” 
  and others are found more extensively in 
the Appendices to this report. We review and update some of these, as they relate to the focus 
of this conference.  
 
8National Bioethics Advisory Commission (2000). Research Involving Human Biological 
Materials: ethical issues and policy guidance, Vol. II: Commissioned papers. Bethesda, MD: U.S. 
Government Printing Office. 
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 Identifiability. A key consideration in determining the extent to which ethical concern is 
implicated in the collection and use of HBM bears on the degree to which  a human subject is 
involved in the research, and particularly whether the biological material can be linked to the 
person from whom it was obtained. 9 The debate about research use of human biological 
materials has been at times complicated by the fact that the language that is used varies and 
often is at odds with the categories used in the applicable federal regulations.  To the extent 
that individuals can be identified, they can be harmed either directly or indirectly. Stanford 
bioinformaticist Russ Altman and colleagues helpfully framed the dilemma facing genomic 
scientists and privacy advocates. 10
                                                          
9 The relevant regulatory provision is found at 45 CFR 46.102(f), referring to identifiable 
private information. 
 Put simply, the more SNPs that are identified, the more an 
individual person can be identified and, therefore, the less privacy protection that can be 
assured. The converse of this relationship holds as well: the fewer SNPs identified, the less one 
is able to make meaningful associations of genotype and phenotype. At the extremes, one can 
imagine two undesirable outcomes of this relationship: absolute privacy protection dramatically 
inhibits research; complete access to SNP information dramatically inhibits privacy protection.  
10 Lin Z, Owen AB, Altman RB. Genetics, Genomic Research Human Subject Privacy. 
(2004) Science Jul 9;305(5681):183 
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The challenge is in identifying the optimal balance between the two concerns – bearing in mind 
that the electronic health record of the near future will come to  
serve as a favored repository or source of genomic information for both clinical and research 
purposes.  Still, “Altman’s Curve” (as we have chosen to call it, see Figure 2), is only a heuristic 
device to capture the real dilemma between 
the need to find genetic relationships of 
significance and the need to ensure adequate 
protection of private information. One of the 
approaches to resolving this dilemma has 
come from empirical research conducted on 
public attitudes about and willingness to participate in biobanking. 
 Informed Consent. The obligation to seek permission to obtain and use parts of an 
individual, whether for research or treatment purposes is among the most  settled issues in 
bioethics and law. At issue in biobanking is not whether to obtain consent, but when, under 
what conditions and with what degree of specificity.11
                                                          
11 An equally exhaustive literature exists on consent. See for example, Sass, H. M. 
(1998). Genotyping in clinical trials: towards a principle of informed request. J Med Philos 23(3): 
288-96; Shickle, D. (2006) The consent problem within DNA biobanks. Stud Hist Philos Biol 
Biomed Sci 37(3): 503-19; Skolbekken, J.-A., L. Ã. y. Ursin, et al. Not worth the paper it's written 
on? Informed consent and biobank research in a Norwegian context.Critical Public Health 15(4): 
335-347; Stegmayr, B. and K. Asplund (2002). Informed consent for genetic research on blood 
 
Figure 2- Altman’s Curve 
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 Public Attitudes. A growing body of evidence exists regarding the public’s willingness to 
donate tissue or other biological material to science in general, and to biobanks in particular. A 
review of the empirical literature conducted on PubMed in early 2009 found no fewer than 60 
studies, with at least 20 surveys published between February 2008 and January 2009. [See 
Appendices].  Space does not permit a thorough review of these analyses, but at the risk of 
simplifying a very robust set of studies undertaken on different groups of people, in different 
countries, under different conditions, being asked different questions, it would appear that in 
recent years there has been a gradual increase in the public’s expression of willingness to 
participate in biobanks.  
 Our own studies in Indiana are consistent with this general claim. Several of these 
surveys are briefly described. In 2006 and 2007 we surveyed cancer patients who contributed 
leftover tissue to the Indiana University Cancer Center Tissue Bank  and found that a clear 
majority of subjects would permit unlimited future research on stored human biological 
materials without re-contact and re-consent, and, further, that a significant minority appear to 
                                                                                                                                                                                           
stored for more than a decade: a population based study. BMJ 325(7365): 634-5. 
Wendler, D. (2006). One-time general consent for research on biological samples. BMJ 
332(7540): 544-7. Williams, G. and D. Schroeder (2004). Human genetic banking: altruism, 
benefit and consent. New Genet Soc 23(1): 89-103. 
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desire ongoing control over future research uses of their tissue. 12  In 2007-2008 when we 
surveyed women in community health clinics to estimate their willingness to donate specimens 
for DNA analysis by needle stick as compared with collection of saliva, the majority of the 279 
women surveyed would do both in high numbers (needle stick: 68.3%;  saliva: 75.7%).13
We also undertook a more comprehensive telephone survey of more than 1,000 Indiana 
adults in 2007 and 2008, one of the aims of which was to assess public confidence in medical 
  In both 
of these surveys, we learned that support for biobanking was modulated by certain factors. For 
example, in our study of cancer patients about two-thirds (62.6%) of respondents agreed or 
strongly agreed that it was “all right” for researchers to use their donated tissue to develop a 
new tool or treatment for profit  though support for “for profit” biobanking varied somewhat 
with this population depending on age, education and other demographic factors.  In our study 
involving women in the community health clinic, we found a number of reasons why they 
indicated an unwillingness to participate, including worries about the use of the specimens, 
violations of privacy, the potential for future discrimination, and the fear surrounding 
unfavorable results.  
                                                          
12 Helft PR, Champion VL, Eckles R, Johnson CS, Meslin EM: Cancer patients' attitudes 
toward future research uses of stored human biological materials. J Empir Res Hum Res Ethics 
2007;2:15-22. 
 
13 Haas DM, Renbarger JL, Meslin EM, Drabiak K, Flockhart D: Patient attitudes toward 
genotyping in an urban women's health clinic. Obstet Gynecol 2008;112:1023-1028. 
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and genetic research.14
• How concerned are you that genetic research is carried out by pharmaceutical, 
biotechnology and other for-profit businesses? 
 Respondents were asked five questions relating to privacy, answering 
each using a scale of 1-10 with 1 being ‘not at all concerned’ and 10 being ‘extremely 
concerned’: 
• How concerned are you that information collected in the course of genetic research 
might be used by people other than the researchers?  
• Specifically, how concerned are you that this information might be used by employers? 
• How concerned are you that this information might be used by health insurance 
companies?  
• How concerned are you that this information might be used by schools?  
 
 Table 1 (opposite) provides 
the demographic data 
relating to each of these 
questions. In general, the 
highest level of concern 
among the public is related 
to the use of genetic 
                                                          
14 IUPUI Survey Research Center. Public attitudes regarding genetic research: Survey 
methods and findings: IU Center for Bioethics, 2009 available at www. bioethics.iu.edu 
Table 1- Concerns About Privacy 
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information by insurance companies.  The group with the highest level of concern comprised 
those approaching retirement (45-64-year-olds) who reported among the highest levels of 
concern over all five of the issues presented.   
Finally, we recently completed a national telephone survey in September 2009 which we 
sought the opinions of close to 400 people about genetic research and the use of personal 
information, including specific questions about identifiability.15
Q2: If I were asked to provide access to my medical records to obtain information that 
could be used for genetic research, I would be willing to give permission for use of my 
records. 
 For example, we asked 
respondents to consider the following question: 
 
On a scale of 1-5, where 1 signified that they “strongly agreed”, and 5 that they “strongly 
disagreed”, the responses from 397 respondents were as follows: (1) 19.8%; (2) 8.10%; (3) 
19.5%; (4) 16.3%; (5) 36.6%. We also asked this question: 
Q5: How confident are you that genetic research is generally carried out in ways that 
protect the privacy and confidentiality of the research subjects involved?   
 
On the same scale (1 = not at all, 5 = extremely concerned), the public sample  (N = 397) 
responded as follows:  (1) 8.40% ; (2) 14.10%; (3) 27.20%; (4)  24.60%; (5) 25.70%.   We also 
asked a series of questions designed to elicit attitudes about the possibility that researchers 
                                                          
15 We are still analyzing the survey results. Data presented in this paper are for 
illustrative purposes only. 
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might be able to identify individuals in published studies with increasing certainty, using 
attacks” such as those proposed by Homer16 and more recently by colleagues from Indiana 
University-Bloomington.17
 
 We first gave an introduction: 
Now I would like for you to imagine that you are invited to participate in a genetic 
research study where you will be asked to give a blood sample that will be analyzed in a 
laboratory.  When the study is completed, the results will be published.  While you will 
not be personally identified by name, address, or any of the other usual ways, there are 
now sophisticated statistical techniques under development that might be able to 
identify you as a participant in the study.  These techniques involve looking at DNA of all 
the people in the study, and then examining the blood samples.  It is possible, therefore, 
to identify you, even though your name was not mentioned in the published article. 
Since the article will be read by other scientists and many other people, it is possible 
that they too might be able to identify you as a participant in the genetics study. 
 
We then asked the following question: 
 
Q7: Knowing this, how concerned would you be in being identified in this way? Please 
select a number between 1 and 5, with 1 being not at all concerned and 5 being 
extremely concerned. 
 
                                                          
16 N. Homer, S. Szelinger, M. Redman, D. Duggan, W. Tembe, J. Muehling, J. V. Pearson, 
D. A. Stephan, S. F. Nelson, and D. W.Craig. Resolving individuals contributing trace amounts of 
dna to highly complex mixtures using high-density snp genotyping microarrays. PLoS Genet, 
4(8):e1000167+, 2008. 
17 Wang R, Li Y, Wang XF, Tang H, Zhou X. Learning Your Identity and Disease from 
Research Papers: Information Leaks in Genome Wide Association Study. Technical Report 
TR680. http://ns2.lam-mpi.org/cgi-bin/techreports/TRNNN.cgi?trnum=TR680. Accessed. 
October 1, 2009. 
 
 
Biobanks and Electronic Health Records  
Ethical and Policy Challenges 
Meslin and Goodman 
 
 
 
Eric M. Meslin and Kenneth Goodman. Biobanks and Electronic Health Records: Ethical and Policy 
Challenges in the Genomic Age. Indianapolis: Center for Applied Cybersecurity Research, Indiana 
University. October 2009. 
 
Page | 16 
Of the 398 people who responded, answers were as follows: (1) 22.40%; (2) 16.10%; (3) 
23.60%; (4) 13.40; (5) 24.50%.  Given these responses, we then probed further to determine 
whether the likelihood of identifying individual persons affected their level of concern. Four 
questions were asked, providing respondents with different probabilities of being identified, 
ranging from < 5% to 95% or more. The Table below lists the responses to the interviewer’s 
question when different probabilities of identifying the individual were given. 
 
It is tempting to accept data of the kind presented above as dispositive – and conclude 
that the public’s opinions ought to guide public policy. We would, however, urge caution in 
drawing such premature conclusions. The first reason for this caution is reflected in the data 
above – we are not at all clear about the explanation for why a greater percentage of people 
would agree to participate in a study where there is a greater (rather than lesser) chance of 
their being identified.18
                                                          
18 As noted above, these data have not been fully analyzed. 
 A second reason for being cautious is explained by a counter-example 
from Australia. 
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The Experience of the Western Australia Data Linkage Unit. For more than three 
decades, the state government of Western Australia has been collecting one of the world’s 
largest administrative health datasets, including birth records, midwives' notifications, cancer 
registrations, inpatient hospital morbidity, in-patient and public out-patient, mental health 
services data and death records.19 Used in combination with medical record audits, the WA 
Dataset provides a platform for comprehensive evaluation of health system performance.  
Moreover, investigators have developed a system for linkage which is aimed at meeting the 
dual goals of protecting privacy and enabling health systems research.20  This “win-win” 
approach results from keeping any identifiable information from the researchers, who only 
need the linked data on exposures and outcomes for their analyses.  Of note, since this 
program has been in place, general requests for access to identifiable data have declined 
markedly.21
                                                          
19 Hobbs MS, McCall MG. Health statistics and record linkage in Australia. J Chronic Dis 
1970;23(5):375-381; Stanley FJ, Croft ML, Gibbins J, et al. A population database for maternal 
and child health research in Western Australia using record linkage. Paediatr Perinat Epidemiol 
1994;8:433-447;Holman CDJ, Bass AJ, Rouse IL, et al. Population-based linkage of health records 
in Western Australia: development of a health services research linked database. Aust N Z J 
Public Health 1999;23:453-459 
  Indeed, when people in the general community were asked if they approved of 
 
20 Kelman CW, Bass AJ, Holman CD. Research use of linked health data--a best practice 
protocol. Aust N Z J Public Health 2002;26:251-255. 
 
21 Trutwein B, Holman CD, Rosman DL. Health data linkage conserves privacy in a 
research-rich environment. Ann Epidemiol 2006;16(4):279-280. 
Biobanks and Electronic Health Records  
Ethical and Policy Challenges 
Meslin and Goodman 
 
 
 
Eric M. Meslin and Kenneth Goodman. Biobanks and Electronic Health Records: Ethical and Policy 
Challenges in the Genomic Age. Indianapolis: Center for Applied Cybersecurity Research, Indiana 
University. October 2009. 
 
Page | 18 
their information being used in this way, they were found not only to be supportive of it, but 
they questioned why it was not already being done.22
Our conclusion from this empirical data is that it is not enough to know that the public 
has concerns (as evinced by the public opinion data above). Instead, it is critical to appreciate 
that the context for these concerns inform the type of tradeoffs between protecting privacy 
and permitting access to information to advance research on human health.  
  
Governance and Regulatory Issues. With the domestic and international proliferation of 
obanks and their associated connections to health information databases, scholarly attention 
has been turning from the ethical issues arising from the construction of biobanks to the ethical 
issues that emerge in their operation and management.  In the years since there has been no 
shortage of guidance documents on these topics. A search of the authoritative HumGen 
database listed 52 international, 38 regional and 204 national guidance documents on the topic 
of biobanks alone.23
                                                                                                                                                                                           
 
  In the United States, a set of federal regulations governs the oversight of 
22  Stanley FJ, Meslin EM Australia Needs a Better System for Health Care Evaluation, 
Medical Journal of Australia (2007); 186: 220-221 
 
23 http://www.humgen.org/int/GB2_p.cfm?mod=1. Accessed October 1, 2009. 
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research involving human subjects, and it is within this regulatory structure that the research 
uses of human biological materials is assessed.24
Many commentators have 
observed that there are significant 
ambiguities in the regulations for 
the protection of human 
subjects.
  
25
                                                          
24 This set of regulations includes but is not limited to the Common Rule (45 CFR 46 
Subpart A ); relevant FDA regulations at 21 CFR 50/56; the HIPAA Privacy Rule 45 CFR 160, 164; 
and the Genetic Information and Non-Discrimination Act. 
 This situation can be 
partly explained by simply 
referring to a pictorial 
representation of the Common 
Rule (see opposite) that 
resembles a “hub and spoke” prepared by NBAC in 2001 to show how 16 federal agencies and 
 
25 National Bioethics Advisory Commission: Research involving human biological 
materials: Ethical issues and policy guidance, volume i : Report and recommendations of the 
national bioethics advisory commission. Bethesda, MD, National Bioethics Advisory 
Commission, 1999; Evans BJ: Inconsistent regulatory protection under the u.S. Common rule. 
Camb Q Healthc Ethics 2004;13:366-379; Evans BJ: Finding a liability-free space in which 
personalized medicine can bloom. Clin Pharmacol Ther 2007;82:461-465.Evans BJ: Seven pillars 
of a new evidentiary paradigm: The food, drug, and cosmetic act enters the genomic era. Notre 
Dame Law Review 2009. 
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offices agreed to be bound by the same “common” set of rules (45 CFR 46, Subpart A), leaving 
more than 50 other agencies to fend for themselves.  But this does not explain why, for 
example, the FDA’s regulations differed in critical ways from those of the Common Rule.26 Still, 
sufficient clarity is evident within the regulatory space provided by existing guidance 
documents to permit considerable local discretion by IRBs.27
 
 In other words, U.S. regulations 
already provide IRBs with the authority they need to make determinations about whether 
consent forms could be constructed to permit blanket consent, and about the adequacy privacy 
and confidentiality protections. 
ELECTRONIC HEALTH RECORDS 
The practice of medicine and nursing necessarily (though not of course sufficiently) require the 
keeping of records. Biobanks are in many respects records, albeit organic ones. More familiarly, 
                                                          
26  Evans BJ, Meslin EM: Encouraging translational research through harmonization of 
FDA and Common Rule informed consent requirements for research with banked specimens. J 
Leg Med 2006;27:119-166 
 
27  Office for Protection from Research Risks: Issues to consider in the research use of 
stored data or tissues, 1997  www.ohrp.gov ; Drabiak-Syed K: State codification of federal 
regulatory ambiguities in biobanking and genetic research. J Leg Med 2009;30:299-327; Wolf 
LE, Lo B: Untapped potential: Irb guidance for the ethical research use of stored biological 
materials. IRB: Ethics & Human Research 2004;26:1. 
 
  
 
Biobanks and Electronic Health Records  
Ethical and Policy Challenges 
Meslin and Goodman 
 
 
 
Eric M. Meslin and Kenneth Goodman. Biobanks and Electronic Health Records: Ethical and Policy 
Challenges in the Genomic Age. Indianapolis: Center for Applied Cybersecurity Research, Indiana 
University. October 2009. 
 
Page | 21 
physicians’ notes about signs and symptoms, treatment decisions and outcomes serve as 
reminders, to guide the care of individual patients; and as a source of information for research, 
to shape the care of all patients. Without stored accounts about what is seen, felt, heard, 
measured and done, there can be no effective medical practice, no sharing, teaching learning of 
any substance or consequence. 
The practice of making notes about patient encounters is ancient and has been 
attributed to Hippocrates, though what survive are case histories intended to be used for 
teaching. Garrison’s 1913 classic, An Introduction to the History of Medicine, notes that in 25 of 
the 42 cases in the Hippocratic corpus, the patients died – and were therefore especially 
instructive; he compares these to the records of Galen, which are boastful and limited to 
remarkable cures and the errors of other practitioners. Hippocrates: “ I have written this down 
deliberately believing it is valuable to learn of unsuccessful experiments and to know the causes 
of their failure.”28
More than a millennium later, the Syrian physician Ishap bin Ali Al Rahwi (CE 854–931) 
suggests in Ethics of the Physician that clinicians had a duty to make two sets of notes with one 
copy to be assessed by a council of physicians to determine if the standard of care had been 
 
                                                          
28 Garrison FH. An Introduction to the History of Medicine, Philadelphia: W.B. Saunders 
Company, 2nd Ed., 1917, p. 88. Note that the Hippocratic corpus is likely a composite, drawn 
from several sources, and there is disagreement among some historians about the very 
existence of a man, Hippocrates, as the author of documents attributed to him. 
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followed. It is apparently the first documented instance of peer review. (The council’s reports 
could later be used in malpractice suits.) 29 Even the most rudimentary data can be of use: John 
Snow’s famous analyses of case reports and maps contributed to halting a cholera epidemic in 
London in 1854.30
The clearest early modern statement of the utter necessity of complete and easily 
accessible medical records is arguably made by Abraham Flexner in his analysis of U.S. medical 
education. The medical record is seen as essential for quality care and the education of those 
who would provide it – in ways not dissimilar to contemporary claims for the utility of biobanks 
for translational medicine and pharmacogenomics: 
 
Pupils are more apt to disappoint than to astonish their teachers; they do not generally 
better their instruction. In consequence hospital records made by internes [sic] graduated 
by these schools are scant and unsystematic … whoever is responsible, poorly kept records 
are very apt to denote inferior bedside instruction. The situation is this: there lies the 
patient; teacher, interne, and students surround the bed. The case is up for discussion. A 
question arises that requires for its settlement now a detail of the patient’s previous 
history, now a point covered by the original physical examination, now something brought 
out by microscopic examination at some time in the course of the disease. If complete, 
accurate, and systematic records hang at the bedside, there is an inducement to ask 
questions; doubtful matters can be cleared up as fast as they are suggested. That, then, is 
                                                          
29 Spier R. The history of the peer-review process. Trends in Biotechnology 
2002;20(8):357-358; Al Kawi MZ. History of medical records and peer review. Ann. Saudi. Med. 
1997;17:277–278; Ajlouni KM, Al-Khalidi U. Medical records, patient outcome, and peer review 
in eleventh-century Arab medicine. Ann. Saudi Med. 1997;17:326–327. 
30 Koch T, Denike K. Crediting his critics’ concerns: Remaking John Snow’s map of Broad 
Street cholera, 1854. Social Science & Medicine 2009;69(8):1246-1251. 
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the place for the records – full records, at that. In few instances are the records full; in still 
fewer are they, full or meager, in easy reach.31
 
 
The 1940s saw the invention of the first programmable electronic computing machines 
(developed in secret as tools of warcraft) and, in temporal coincidence,  the policy decision that 
properly maintained medical records should be a requirement for hospital accreditation. Within 
a generation, physicians were experimenting with, developing and, well, fooling around with 
computers as storage devices for those records. There are many reasons why it made sense to 
explore the utility of information technology. They include: 
 Human memory is fallible, variable and, for certain complex information, short. The 
clinical encounter generates too much information to recall accurately. This was, in one 
degree or another, always a challenge, but given the amount of clinical information 
generated by the modern clinician it became clear that storing this information on paper 
is feckless and perhaps even futile. 
 Even if one could easily and swiftly find the information needed for patient care, it was 
difficult to analyze. Computers make it easy to track and compare lab values, diagnoses 
and prescriptions, say, over time.  
 Information technology enables analyses that bear on change, quality, error and other 
phenomena. A computer lets one compare the patients on Ward A (or Hospital X) to 
those on Ward B (or Hospital Y), for instance. Simple reminder and alert systems run on 
quotidian clinical data. 
 Computers support research which would otherwise be impossible, or at least 
impossibly tedious. 
 Information technology supports the kinds of analyses and assessments that now go by 
the names of “comparative effectiveness research” and “meaningful use.” 
 
                                                          
31 Flexner A. Medical Education in the United States and Canada, Bulletin Number Four 
(The Flexner Report). New York: The Carnegie Foundation for the Advancement of Teaching, 
1910. 
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Here is the case, made more than two decades ago, for “Fully operational computer-
stored medical record systems” –  
These systems have demonstrated three kinds of benefits: (1) Computer-stored medical 
records can solve many of the logistic problems of finding, organizing, and reporting 
patient information that occur with purely paper systems. (2) They can improve the 
efficiency and accuracy of physicians' decisions by performing calculations and by 
identifying clinical events that need attention. (3) They can guide future policies and 
practices by analyzing past clinical experience within a hospital or a physician's office.32
 
 
If this is true, then something remarkable has happened, or is happening. Consider that 
contemporary bioethics has in some key respects been about the appropriate use of (new) 
technology. Generally, scholars have tried to determine whether a tool or device should be 
used at all and, if so, which constraints should be in place. Put differently, bioethics has been 
about finding arguments to support the recommendations to stop, slow down, beware. Organ 
transplantation, the use of machines in end-of-life care, gene therapy, stem cell research and so 
on and on were about controversy and the need to determine the scope of appropriate use. 
But what if there were machines which, it could be argued, were essential or necessary for high 
quality care of all patients? Were that the case, it would be blameworthy not to use the 
                                                          
32 McDonald CJ, Tierney WM. Computer-stored medical records: their future role in 
medical practice. JAMA 1988;259(23):3433-40. 
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machines – for all patients.33
More than two decades of research have demonstrated that the establishment, 
implementation and dissemination of health information technologies (HIT) raise profound 
ethical, legal and social issues for patients, clinicians, researchers and society.
 It is only in epidemiology and public health that we see such 
strong imperatives to study and use certain tools for the benefit of all. It might be that the use 
of biobanks will constitute another such imperative. 
34
                                                          
33 Miller RA, Schaffner KF, Meisel A. Ethical and Legal Issues Related to the Use of 
Computer Programs in Clinical Medicine. Annals of Internal Medicine 1985;102:529-537. 
  With the 
passage of the American Recovery and Reinvestment Act of 2009 (ARRA) comes the promise of 
a profound and comprehensive expansion of the use of health information technology in health 
care and society, and with it a commensurate set of ethical and policy issues. Developments in 
health information technology are sufficiently challenging to occupy ethical and policy analysis, 
but when coupled with parallel and interconnected developments in the life sciences – 
mapping and sequencing the human genome, the proliferation of electronic health records and 
the advent of  real-time research data sharing and exchange –  HIT generates issues that extend 
well beyond concerns about privacy protection and confidentiality of medical information: 
 
34 Goodman KW., ed., Ethics, Computing and Medicine: Informatics and the 
Transformation of Health Care. New York: Cambridge University Press, 1998; Goodman KW, 
Miller R. Ethics and Health Informatics: Users, Standards and Outcomes. In EH Shortliffe et al., 
eds., Medical Informatics: Computer Applications in Health Care and Biomedicine, 3rd ed. New 
York: Springer-Verlag, 2006: 379-402. 
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access to and control of personal health records by patients, health care providers, community 
service organizations; data identification and de-identification in biobanks; dissemination of risk 
information for use in all-hazards preparation and response; emergency public health 
informatics (EPHI); bioinformatics; computational decision support; open source/intellectual 
property; secondary use of information by government and industry; and the growth of  
telemedicine and telehealth.  
 
Ethical Issues in the Development and Use of Electronic Health Records 
 The paper-based medical record, which continues to predominate in U.S. practices, 
clinics and hospitals, raises ethical and security issues insofar as: 
 Someone not authorized or supposed to view them might do so at their points of use or 
storage. Consider a passerby, a family member, an orderly deciding to have a peek at a 
patient’s chart. 
 Records might be improperly transported or discarded. Patient charts have been found 
in the street, in dumpsters and in other places not connected to patient care. 
 Paper charts might be used inappropriately, as for instance when they are removed 
from clinic or hospital and taken to a clinician’s home for review or research, say, and 
are overseen by family members, for instance. 
 
In fact, one could argue, privacy and confidentiality are more at risk when people speak 
carelessly about a patient than they are when patient information is stored in paper records. At 
any rate, the evolution and spread of electronic health records (EHR) and, more recently, 
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personal health records (PHR)35
 The challenge posed by any system of record retention for medical information is simply 
stated: How do we make information about patients easily available to those who need it for 
patient care and other legitimate uses, and unavailable – difficult or impossible to access – for 
all others? Among the corollaries: 
 have changed the way we (need to) think about information 
privacy and security – even as it agreed that paper records are too inefficient, clumsy and 
difficult to access and learn from. 
 Will electronic records alter privacy and confidentiality breach risks? 
 What happens when records are shared or distributed across data bases? What security 
risks arise when digitized health data and information are stored, replicated and 
transmitted? 
 How will personal health records – electronic tools with which patients view and 
manage their own health information – alter the privacy landscape? 
 What will be the effects on health care and information security when, in a 
pharmacogenomic world, EHRs are linked to biobanks (and, for that matter, when some 
of the information contained in biological material becomes an integral part of the 
EHR)?  
 What is the relationship between information security practices developed to safeguard 
data from corruption and inadvertent and intentional alteration and practices 
developed to protect privacy and confidentiality? 
 
                                                          
35 The first study of ethical, legal and social issues raised by PHRs was Project 
HealthDesign, Robert-Wood Johnson Foundation-funded initiative begun in 2007. Among 
findings by a University of Miami team is that in an era of social networking and other on-line 
interactions, traditional conceptions of privacy are shifting, and that privacy itself is a 
somewhat vaguer concept than customarily thought. For instance, young people especially are 
far more inclined than expected to allow medical information to be shared by others who are 
not health professionals. See http://www.projecthealthdesign.org/overview-
phr/ELSIgroupresources for a list of ethics reports from Project HealthDesign. 
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It has, further, been argued for some time that the electronic health record is or can be 
more secure than paper records, in part because, unlike paper, an electronic record can be 
sculpted, structured or secured to impede or prevent inappropriate access.36 Many of the 
mechanisms to achieve this security have already been put in place and, indeed, have become 
the standard for health care organizations: password and login requirements to access records; 
audit trails, which record the identity of all those who have viewed a record; encryption 
standards for data transmission; etc. Indeed, there is a growing body of professional and 
regulatory oversight addressing the security of records, including FDA requirements for audit 
trails (21 CFR Part 11).37  In fact, evolving security standards have identified the “trusted 
insider” as among the most insidious sources of inappropriate access.38
                                                          
36 Barrows R, Clayton P. Privacy, confidentiality and electronic medical records. J Am 
Med Inform Assoc 1996;3:139-48.  
 A trusted insider has a 
login and perhaps even some plausible (but not actual) need to access a record; consider the 
hospital clinician who wants to find out why his sister’s partner is visiting the infectious disease 
 
37 The U.S. National Institute of Standards and Technology is a key source of guidance on 
a variety of information technology standards. See “NIST Special Publication 800-12: An 
Introduction to Computer Security - The NIST Handbook,” Chapter 8, for an analysis of audit 
trails. Available at http://csrc.nist.gov/publications/nistpubs/800-12/800-12-html/.  
 
38 Office of Technology Assessment. Report Brief: Protecting Privacy in Computerized 
Medical Information. Washington, D.C.:  U.S. Government Printing Office, 1993. 
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clinic ….).39
More than a decade and a half ago, in a report to the Secretary of the U.S. Department 
of Health and Human Services, the Workgroup for Electronic Data Interchange, a public-private 
task force, noted,  
 This means that one of the greatest sources of concern for EHRs is of remote or 
offsite access. 
Historically, providers have stored medical information and filed health insurance claims 
on paper.  The paper medium is cumbersome and expensive, two factors that led to the 
call for the use of EDI [electronic data interchange].  Ironically, it is this “negative” 
aspect of the paper medium (its cumbersome nature) that has minimized the risk of 
breaches of confidentiality.  Although a breach could occur if someone gained access to 
health records or insurance claim forms, the magnitude of the breach was limited by the 
sheer difficulty of unobtrusively reviewing large numbers of records or claim forms. … 
From the provider perspective, EDI changes the environment dramatically.  … Stringent 
security protocols may make it more difficult for intruders to access patient-identifiable 
data.  If the security measures are overcome and access is attained, however, the 
electronic medium will potentially allow for remote and unauthorized review of 
unlimited health information.  It will greatly increase the dimension of inadvertent and 
intentional breaches of confidentiality.40
 
 
Now, the adoption of various mechanisms of encryption and firewall protection can address 
these concerns in varying degrees, but there has been for some time generally broad 
                                                          
39 For an overview of security and privacy ethics and standards, see Cushman R, Privacy 
/ Data Protection Project, University of Miami, available at 
http://privacy.med.miami.edu/index.htm. The “Encyclopedia” entries under “security” give 
synopses of core requirements of HIPAA’s Security Standard and Rule. 
40 Workgroup for Electronic Data Interchange. Report to the Secretary of the U.S. 
Department of Health and Human Services. Washington, D.C.: Workgroup for Electronic Data 
Interchange, 1992: appendix 4,  pp. 3-4. 
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agreement that security mechanisms alone are just inadequate to the task of confidentiality 
protection. They are necessary but inadequate: 
There is a tendency to focus on technical measures, such as encryption, when discussing 
information security. Relatively simple physical protections, such as restricting access to 
areas with computers, fax machines, etc., can be just as important. … Most important 
are the “administrative” (policy and procedural) efforts, from the rules about “who may 
see what” to details such as how userids and passwords are disseminated. Even the 
most sophisticated technical and physical measures will be defeated by bad practices.41
 
 
This insight is captured in many respects by the Security Rule under the Health Insurance 
Portability and Accountability Act – HIPAA: 
 
The general requirement of the Security Rule can be simply stated: covered entities that 
“collect, maintain, use or transmit” PHI in electronic form must construct “reasonable 
and appropriate administrative, physical and technical safeguards” that ensure integrity, 
availability and confidentiality. Such measures – notably in the form of policies and 
procedures – must provide protection against “any reasonably anticipated threats or 
hazards.” 
That construction of administrative, physical and technical safeguards can be 
described as including three major steps for the covered entity: 
 “assess potential risks and vulnerabilities" to electronic PHI that it maintains 
or transmits; 
 “develop, implement and maintain appropriate security measures” given 
those anticipated risks; and 
 document those measures and keep them current. 
                                                          
41 Cushman R, Privacy / Data Protection Project, University of Miami, Encyclopedia entry 
“Security and Data Protection,” available at 
http://privacy.med.miami.edu/glossary/xd_security_basicdef.htm. Emphasis added. 
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Safeguards must also “ensure compliance” with the requirements by the covered 
entity's officers and employees – hence this Rule, like the Privacy Rule, has a training 
component.42
 
 
Aspects of these requirements have been known for some time, and they point to what 
should be regarded as a suite of best practices for applied ethics in the domain of electronic 
health records and perhaps especially so when those records are merged with or linked to 
biobanks. Generally, there are recognized to be three intertwined approaches: public policy 
initiatives, including laws that penalize egregious abuses; technological standards, including the 
likes of audit trails and encryption; and education and training.43
                                                          
42 Ibid., “Security Standard/Rule (HIPAA),” 
http://privacy.med.miami.edu/glossary/xd_security_stds.htm 
 This last is too often 
overlooked and, in consequence, too infrequently embraced. Health professionals and others 
who are entrusted with patient information have ancient duties to safeguard that information. 
The moral obligations to protect privacy and confidentiality are uncontroversial, but the 
foundations of privacy rights are obscure to some. This is a teaching moment. The easy cases 
(don’t sell patient data to businesses without patient consent) might require little exegesis, but 
more difficult cases (what if EHR information can be used to warn third parties of health risks? 
how should biobanks data about an individual be communicated to a potentially affected family 
 
43 Alpert SA, Health care information: access, confidentiality, and good practice, in 
Goodman KW, ed., Ethics, Computing, and Medicine: Informatics and the Transformation of 
Health Care, Cambridge: Cambridge University Press, 1998, pp. 75-101. 
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member?) require some grounding in the processes for balancing competing values. This, too, is 
fertile ground for educators. 
The relationship between privacy and consent, considered earlier, points to the 
importance of sharing with learners empirical data that bears on the question of secondary, 
tertiary and n-ary use of health information stored in EHRs. A growing body of research 
parallels the Western Australian experience and “suggests that patients are in fact willing to 
share their information and, indeed, that privacy concerns do not necessarily pose the kinds of 
constraints and inhibitions customarily invoked to limit information sharing.”44
This is rarely as important as it is when considering the utility of EHRs and PHRs for 
public health and epidemiology: 
 In addition to 
being rich in potential applications to public policy, studies about patient preferences (a key 
component of most definitions of evidence-based practice) can inform curricula that provide 
guidance and standards for developing public policy when values are in (potential) conflict.  
… patients, clinicians and society have generally uncontroversial duties to support civil 
society’s public health mission, information technology supports this mission, and the 
effects of automated and computerized public health surveillance are likely to have little 
if any effect on the clinician-patient relationship. … nevertheless … electronic public 
health surveillance raises interesting and important ethical issues, some of which can be 
addressed if not resolved by empirical research, especially regarding patient preferences 
                                                          
44 Goodman KW. Ethics, information technology and public health: New challenges for 
the clinician-patient relationship, Journal of Law, Medicine and Ethics, in press, citing  Marquard 
JL, Brennan PF. Crying wolf: Consumers may be more willing to share medication information 
than policymakers think. Journal of Health Information Management 2009;23: 26-32. 
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about secondary use of health data and their moral obligation to contribute to 
population-based health.45
 
 
 
Ongoing Challenges 
 
We have outlined a set of ethical and policy challenges raised by both repositories of human 
biological material and electronic health records. It is or should be uncontroversial that the 
future will see genomic data and information become an integral part of the patient record, 
with potentially great changes to and challenges for clinical and research practice and ethics. 
Thus, while no list of continuing challenges can be exhaustive, we note for further discussion 
the following set of questions: 
 How should the current system for the protection of human subjects, which may still be 
ill-equipped to address the ethical issues arising from studies involving HBMs or EHRs, 
be modified to adapt to these new technologies?  
 When should individual research results be returned to subjects? 
 How should harms be assessed when results are of unknown clinical significance? 
 What clinical, scientific and ethical challenges are raised when genomic information 
becomes a component of records which for thousands of years have been restricted to 
accounts of somewhat more pedestrian observations, data and actions? 
 As the need for greater access to identifiable health information collides with the 
opportunity for undertaking studies that require greater access to genotypic 
information, how will prevailing clinical and research paradigms adapt? 
 
 
Recommendations 
 
                                                          
45 Goodman, ibid. 
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 Detailed investigators are necessary to explore current and potential links between 
biobanks and EHRs and PHRs. 
 There should be more and better research on patient preferences regarding secondary 
use of information in electronic records. 
 Increased attention should be devoted to ethical analyses of the consequences of 
digitizing parts of biobank contents. 
 Development of curricula for health professionals, researchers, patients, patients as 
potential subjects (or sources of biological material for research) and others must be 
regarded as socially, morally and political urgent. 
